Soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin at delivery. 1991

A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
Immunology Unit, Hospital La Paz, Madrid Spain.

In this work we have quantified soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin (beta 2 m) in sera of HIV+ or HIV- mothers at delivery and in cord blood sera of their newborn children. The results obtained for beta 2 m show that cord blood sera of newborn children have higher concentrations than their mothers, implying that most of the beta 2 m in the newborn is self-produced as described previously. s-HLA serum concentrations in the newborn children are significantly lower than in their mothers or in age-matched controls. Moreover, HIV+ mothers have significantly higher serum concentrations than HIV- mothers or an age-matched control group. These results suggest that s-HLA does not cross the placental barrier.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
April 1997, Human immunology,
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
January 1989, International archives of allergy and applied immunology,
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
December 2003, Orbit (Amsterdam, Netherlands),
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
January 1984, Experimental and clinical immunogenetics,
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
January 1987, Immunogenetics,
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
August 1982, Journal of immunology (Baltimore, Md. : 1950),
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
September 1993, Journal of immunology (Baltimore, Md. : 1950),
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
July 1994, Human immunology,
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
January 1994, Vox sanguinis,
A Ferreira, and M C García Rodríguez, and F Omeñaca, and A Jiménez, and L M Villar, and P Gonzalez-Porqué, and G Fontán
March 1986, Tissue antigens,
Copied contents to your clipboard!